Cargando…
Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635507/ https://www.ncbi.nlm.nih.gov/pubmed/37943834 http://dx.doi.org/10.1371/journal.pone.0294382 |
_version_ | 1785133011118850048 |
---|---|
author | Rounis, Konstantinos Makrakis, Dimitrios Papadaki, Chara Monastirioti, Alexia Vamvakas, Lambros Kalbakis, Konstantinos Gourlia, Krystallia Xanthopoulos, Iordanis Tsamardinos, Ioannis Mavroudis, Dimitrios Agelaki, Sofia |
author_facet | Rounis, Konstantinos Makrakis, Dimitrios Papadaki, Chara Monastirioti, Alexia Vamvakas, Lambros Kalbakis, Konstantinos Gourlia, Krystallia Xanthopoulos, Iordanis Tsamardinos, Ioannis Mavroudis, Dimitrios Agelaki, Sofia |
author_sort | Rounis, Konstantinos |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10635507 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-106355072023-11-10 Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study Rounis, Konstantinos Makrakis, Dimitrios Papadaki, Chara Monastirioti, Alexia Vamvakas, Lambros Kalbakis, Konstantinos Gourlia, Krystallia Xanthopoulos, Iordanis Tsamardinos, Ioannis Mavroudis, Dimitrios Agelaki, Sofia PLoS One Correction Public Library of Science 2023-11-09 /pmc/articles/PMC10635507/ /pubmed/37943834 http://dx.doi.org/10.1371/journal.pone.0294382 Text en © 2023 Rounis et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Correction Rounis, Konstantinos Makrakis, Dimitrios Papadaki, Chara Monastirioti, Alexia Vamvakas, Lambros Kalbakis, Konstantinos Gourlia, Krystallia Xanthopoulos, Iordanis Tsamardinos, Ioannis Mavroudis, Dimitrios Agelaki, Sofia Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study |
title | Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study |
title_full | Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study |
title_fullStr | Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study |
title_full_unstemmed | Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study |
title_short | Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study |
title_sort | correction: prediction of outcome in patients with non-small cell lung cancer treated with second line pd-1/pdl-1 inhibitors based on clinical parameters: results from a prospective, single institution study |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635507/ https://www.ncbi.nlm.nih.gov/pubmed/37943834 http://dx.doi.org/10.1371/journal.pone.0294382 |
work_keys_str_mv | AT rouniskonstantinos correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy AT makrakisdimitrios correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy AT papadakichara correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy AT monastiriotialexia correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy AT vamvakaslambros correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy AT kalbakiskonstantinos correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy AT gourliakrystallia correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy AT xanthopoulosiordanis correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy AT tsamardinosioannis correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy AT mavroudisdimitrios correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy AT agelakisofia correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy |